Spotlights

The shareholders of AUXESIS PHARMA HOLDING AB (publ) with organization number 559195-6486 are hereby invited to the annual general meeting on June 16, 2023 at

New updated Pitch, Memorandum and Scenario Valuation 2023 for download. Auxesis Pharma Pitch 2023 Download here Auxesis Pharma Memorandum 2023 Download here Auxesis Pharma Scenario

Document regarding registration of sharholders deposit information is available for download in the Investor Hub.

Euroclear AUXESIS PHARMA HOLDING AB (publ) has now entered into an agreement with the issuance institute Avanza Sweden. All shareholders will be registered with Euroclear

Valuation AUXESIS 03/2023 Scenario valuation of the shares in AUXESIS PHARMA HOLDING AB (publ) prior to the launch of the company’s analgesic product ASA.P® is

Investor Invitation We are excited to invite you to our first Investor Forum monday the 30th of january at the Karolinska Institute, Huddinge, Sweden. On

News Euroclear Sweden AUXESIS PHARMA HOLDING AB (publ) register of shareholders is in process of being digitalised and transferred to the Euroclear system. As a client

Update There is exciting news in Auxesis Pharma. Trademarks, new areas of application, clinical studies and trials, production facilities, to name a few. Complete pdf

Do you want to join the journey? AUXESIS PHARMA HOLDING AB (publ) is increasing its stock with maximum 600.000 shares at a price of SEK 59 sek/share. Click below and you will